Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
High-Dose Convalescent Plasma for Treatment of Severe COVID-19.
Emerg Infect Dis. 2022 Mar;28(3):548-555. doi: 10.3201/eid2803.212299. Epub 2022 Jan 26.
Emerg Infect Dis. 2022.
PMID: 35081022
Free PMC article.
Clinical Trial.
Histo-blood group A is a risk factor for severe COVID-19.
Garibaldi PMM, Oliveira LC, da Fonseca BA, Auxiliadora-Martins M, Miranda CH, Almado CEL, Langhi DM, Gilio RN, Palma LC, Gomes BBM, Bottura C, Barrientto LC, Donadel CD, Calado RT, De Santis GC.
Garibaldi PMM, et al. Among authors: gilio rn.
Transfus Med. 2022 Jun;32(3):248-251. doi: 10.1111/tme.12796. Epub 2021 Jun 3.
Transfus Med. 2022.
PMID: 34085363
Free PMC article.
Item in Clipboard
Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID).
Lemos ACB, do Espírito Santo DA, Salvetti MC, Gilio RN, Agra LB, Pazin-Filho A, Miranda CH.
Lemos ACB, et al. Among authors: gilio rn.
Thromb Res. 2020 Dec;196:359-366. doi: 10.1016/j.thromres.2020.09.026. Epub 2020 Sep 21.
Thromb Res. 2020.
PMID: 32977137
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite